Deracoxib is a selective cyclooxygenase 2 inhibitor used in veterinary medicine. It is a sulfonamide and organofluorine compound belonging to the pyrazole class.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 169590-41-4
Cosyntropin
pharmaceutical raw material
(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one
pharmaceutical raw material
(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one
pharmaceutical raw material
(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one
pharmaceutical raw material
Celecoxib
pharmaceutical raw material
Mavacoxib
pharmaceutical raw material
4-Desmethyl-2-methyl Celecoxib
pharmaceutical intermediate
CHEMBL29923
pharmaceutical raw material
4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)pyrazol-1-yl]benzenesulfonamide
WAZQAZKAZLXFMK-UHFFFAOYSA-N
COC1=C(C=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)F)F